We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
-5.42%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
-$134M
(-2%)
Cap. Flow
+$939M
Cap. Flow
% of AUM
14.59%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
1,160
New
141
Increased
414
Reduced
331
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$395M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$59M |
| 3 |
Visa
V
|
+$46.9M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$44.8M |
| 5 |
Walt Disney
DIS
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illinois Tool Works
ITW
|
+$48M |
| 2 |
CVS Health
CVS
|
+$36.5M |
| 3 |
Northern Trust
NTRS
|
+$18.6M |
| 4 |
First Trust Expanded Technology ETF
XPND
|
+$17.2M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.93% |
| 2 | Financials | 8.94% |
| 3 | Healthcare | 8.07% |
| 4 | Industrials | 7.57% |
| 5 | Consumer Discretionary | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
901
DELISTED
Invacare Corporation
IVC
| $98K | ﹤0.01% |
69,477
+55,546
| +399% | +$119K |
|
|
PIPP
902
DELISTED
Pine Island Acquisition Corp.
PIPP
| $98K | ﹤0.01% |
10,000
| – | – |
|
|
MVF
903
DELISTED
BlackRock MuniVest Fund
MVF
| $92K | ﹤0.01% |
11,256
| – | – |
|
904
iShares MSCI EAFE Value ETF
EFV
$28.4B
| $89K | ﹤0.01% |
85,488
-2,500
| -3% | -$127K |
|
905
Banco Santander
SAN
$199B
| $89K | ﹤0.01% |
26,932
-15,930
| -37% | -$55.8K |
|
|
SRTA
906
Strata Critical Medical Inc
SRTA
$441M
| $85K | ﹤0.01% |
10,000
| – | – |
|
907
Mizuho Financial
MFG
$123B
| $85K | ﹤0.01% |
33,248
-58,568
| -64% | -$160K |
|
908
Nokia
NOK
$49.5B
| $81K | ﹤0.01% |
14,684
-10,466
| -42% | -$58K |
|
909
Nomura Holdings
NMR
$28.1B
| $78K | ﹤0.01% |
18,393
-25,631
| -58% | -$116K |
|
910
Avantis International Small Cap Value ETF
AVDV
$18.8B
| $69K | ﹤0.01% |
+19,977
| New | +$1.26M |
|
911
Avantis US Small Cap Value ETF
AVUV
$30.5B
| $62K | ﹤0.01% |
39,745
+22,636
| +132% | +$1.79M |
|
|
BLUE
912
DELISTED
bluebird bio
BLUE
| $62K | ﹤0.01% |
634
+92
| +17% | +$12.1K |
|
913
Lloyds Banking Group
LYG
$87.1B
| $61K | ﹤0.01% |
24,508
-44,090
| -64% | -$117K |
|
|
LTCH
914
DELISTED
Latch, Inc. Common Stock
LTCH
| $60K | ﹤0.01% |
+13,842
| New | +$72.4K |
|
915
Dianthus Therapeutics
DNTH
$5.61B
| $58K | ﹤0.01% |
1,250
| – | – |
|
916
OLB
OLB
$4.56M
| $53K | ﹤0.01% |
3,000
| – | – |
|
|
TEF
917
DELISTED
Telefonica
TEF
| $53K | ﹤0.01% |
11,057
-33,451
| -75% | -$149K |
|
918
Banco Bradesco
BBD
$38.6B
| $52K | ﹤0.01% |
12,087
-9,036
| -43% | -$33.2K |
|
|
OTLY
919
Oatly Group
OTLY
$456M
| $51K | ﹤0.01% |
+509
| New | +$67.1K |
|
920
Standard BioTools
LAB
$307M
| $43K | ﹤0.01% |
12,100
-10
| -0.1% | -$35 |
|
|
THER
921
DELISTED
THERATECHNOLOGIES INC COM
THER
| $42K | ﹤0.01% |
16,947
| – | – |
|
922
Rigel Pharmaceuticals
RIGL
$699M
| $37K | ﹤0.01% |
1,230
| – | – |
|
923
Gerdau
GGB
$9.68B
| $33K | ﹤0.01% |
25,019
+1,529
| +7% | +$6.57K |
|
924
Invesco Mortgage Capital
IVR
$768M
| $33K | ﹤0.01% |
+1,464
| New | +$36K |
|
925
Omega Healthcare
OHI
$15.4B
| $32K | ﹤0.01% |
+56,909
| New | +$1.68M |
|
Similar funds
Cerity Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Cerity Partners held 1,160 positions worth $6.44B, down 2% from $6.57B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Cerity Partners deployed $939M of net new capital in Q1 2022, opening 141 new positions and adding to 414 existing holdings. Its largest new stake was Vanguard Russell 3000 ETF: 93,277 shares worth $17.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Illinois Tool Works, an estimated $48M trimmed.
- Cerity Partners's largest Q1 2022 buy was Vanguard Russell 3000 ETF: 93,277 shares worth $17.7M.
- Cerity Partners added most to Vanguard S&P 500 ETF in Q1 2022, an estimated $395M increase.
- Cerity Partners's biggest Q1 2022 reduction was Illinois Tool Works, cutting an estimated $48M.
- Cerity Partners fully exited First Trust Expanded Technology ETF in Q1 2022, selling an estimated $17.2M.
- Cerity Partners's ten largest holdings make up 35% of its $6.44B portfolio in Q1 2022.
- Cerity Partners opened 141 new positions and closed 220 in Q1 2022.
- Cerity Partners's portfolio value fell 2% quarter-over-quarter to $6.44B.
Based on Cerity Partners's 13F filing for Q1 2022, filed 25 Apr 2022.